A Strategic Target Rescues Trimethoprim Sensitivity in Escherichia coli
A Strategic Target Rescues Trimethoprim Sensitivity in Escherichia coli
复制标题
DOI：
10.1016/j.isci.2020.100986
复制
发表时间：
2020-04-24
期刊：
影响因子：
5.8
通讯作者：
Chandra, Nagasuma
中科院分区：
文献类型：
--
作者：
Bhosle, Amrisha;Datey, Akshay;Chandra, Nagasuma
Trimethoprim, a preferred treatment for urinary tract infections, is becoming obsolete owing to the rapid dissemination of resistant E. coli. Although direct resistance mechanisms such as overexpression of a mutant FolA and dfr enzymes are well characterized, associated alterations that drive or sustain resistance are unknown. We identify the repertoire of resistance-associated perturbations by constructing and interrogating a transcriptome-integrated functional interactome. From the cross talk between perturbations in stress-response and metabolic pathways, we identify the critical dependence on serine hydroxymethyltransferase (GlyA) as an emergent vulnerability. Through its deletion, we demonstrate thatGlyA is necessary to sustain high levels of resistance in both laboratory-evolved resistant E. coli and a multidrug-resistant clinical isolate. Through comparative evolution, we show that the absence of GlyA activity decelerates the acquisition of resistance in E. coli. Put together, our results identify GlyA as a promising target, providing a basis for the rational design of drug combinations.
